| Earnings (Loss) Per Share |
14. Earnings (Loss) Per Share Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average shares of common stock outstanding. For purposes of calculating diluted earnings per share, the denominator includes both the weighted average shares of common stock outstanding and dilutive common stock equivalents. Dilutive common stock equivalents consist of stock options, restricted stock unit awards and warrants calculated under the treasury stock method. The calculations of earnings (loss) per share are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
(In thousands, except per share amounts) |
|
2021 |
|
|
2020 |
|
|
2019 |
|
Basic earnings (loss) per Common Share: |
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of tax |
|
$ |
133,975 |
|
|
$ |
(132,619 |
) |
|
$ |
(238,411 |
) |
Net loss attributable to non-controlling interests |
|
|
0 |
|
|
|
0 |
|
|
|
424 |
|
Net income (loss) from continuing operations attributable to Allscripts Healthcare Solutions, Inc. stockholders |
|
|
133,975 |
|
|
|
(132,619 |
) |
|
|
(237,987 |
) |
Income from discontinued operations, net of tax |
|
|
463 |
|
|
|
833,026 |
|
|
|
55,809 |
|
Net income (loss) attributable to Allscripts Healthcare Solutions, Inc. stockholders |
|
$ |
134,438 |
|
|
$ |
700,407 |
|
|
$ |
(182,178 |
) |
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
130,140 |
|
|
|
159,281 |
|
|
|
166,306 |
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) from continuing operations per Common Share |
|
$ |
1.03 |
|
|
$ |
(0.83 |
) |
|
$ |
(1.43 |
) |
Basic earnings from discontinued operations per Common Share |
|
$ |
0.00 |
|
|
$ |
5.23 |
|
|
$ |
0.33 |
|
Net earnings (loss) attributable to Allscripts Healthcare Solutions, Inc. stockholders per Common Share |
|
$ |
1.03 |
|
|
$ |
4.40 |
|
|
$ |
(1.10 |
) |
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per Common Share: |
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of tax |
|
$ |
133,975 |
|
|
$ |
(132,619 |
) |
|
$ |
(238,411 |
) |
Net loss attributable to non-controlling interests |
|
|
0 |
|
|
|
0 |
|
|
|
424 |
|
Net income (loss) from continuing operations attributable to Allscripts Healthcare Solutions, Inc. stockholders |
|
|
133,975 |
|
|
|
(132,619 |
) |
|
|
(237,987 |
) |
Income from discontinued operations, net of tax |
|
|
463 |
|
|
|
833,026 |
|
|
|
55,809 |
|
Net income (loss) attributable to Allscripts Healthcare Solutions, Inc. stockholders |
|
$ |
134,438 |
|
|
$ |
700,407 |
|
|
$ |
(182,178 |
) |
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
130,140 |
|
|
|
159,281 |
|
|
|
166,306 |
|
Plus: Dilutive effect of stock options, restricted stock unit awards and warrants |
|
|
8,518 |
|
|
|
0 |
|
|
|
0 |
|
Weighted-average common shares outstanding assuming dilution |
|
|
138,658 |
|
|
|
159,281 |
|
|
|
166,306 |
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) from continuing operations per Common Share |
|
$ |
0.97 |
|
|
$ |
(0.83 |
) |
|
$ |
(1.43 |
) |
Diluted earnings from discontinued operations per Common Share |
|
$ |
0.00 |
|
|
$ |
5.23 |
|
|
$ |
0.33 |
|
Net earnings (loss) attributable to Allscripts Healthcare Solutions, Inc. stockholders per Common Share |
|
$ |
0.97 |
|
|
$ |
4.40 |
|
|
$ |
(1.10 |
) |
As a result of the loss from continuing operations, net of tax for the years ended December 31, 2020 and 2019, we used basic weighted-average common shares outstanding in the calculation of diluted earnings (loss) per share, since the inclusion of any stock equivalents would be anti-dilutive. The following stock options, restricted stock unit awards and warrants are not included in the computation of diluted earnings (loss) per share as the effect of including such stock options, restricted stock unit awards and warrants in the computation would be anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
(In thousands) |
|
2021 |
|
|
2020 |
|
|
2019 |
|
Shares subject to anti-dilutive stock options, restricted stock unit awards and warrants excluded from calculation |
|
|
0 |
|
|
|
42,845 |
|
|
|
27,945 |
|
|